DBTC - The Medical Stock to Own for 2005, Omega TradeStation Email Archive

Welcome to The January Edition of The Savvy Investor,

Each month The Savvy Investor analysts study, research, and examine hundreds of stocks, in an effort to pinpoint the one with the most promise.

This month's pick:	Diabetic Treatment Centers of America Inc
Interactive Chart:	Recent Price:	$.61 +3.45%
Industry:	Healthcare Providers

According to the U.S. Centers for Disease Control and Prevention (CDC), the incidence of diabetes has jumped nearly 50% in the past 10 years. Currently, 18.2 million Americans have diabetes. However, a study released earlier this year by the CDC estimates that, if current trends continue, the United States may see as many as 30 million with diabetes by as early as 2030 More...

Patented Technology, Focused Growth, Growing Demand -- Arden Oliphant, CEO of Diabetic Treatment Centers of America Inc., interviewed on TradersNation. Audio

The United States will spend approximately $130 billion this year on diabetic health care, the same amount it is spending in Iraq in ’04.

One American in three born after 2001 will develop diabetes during his or her lifetime.

A 10-year study by the National Institute of Health reports that at least 37% of Type 1 and Type 2 diabetics will need PIT therapy within 10 years of the disease’s progression.

DBTC's patented treatment is FDA-certified and Fully Approved for Medicare and Insurance Reimbursement.

With a market of 2 – 3 million people in the U.S., and many millions of other severe diabetics world-wide, the need is desperate and HUGE.

PIT is the first effective treatment that actually stops and even reverses the terrible complications, returning a diabetic to a more normal life. A diabetic visits a clinic for three one-hour treatments over a six hour period, sits in a chair attached to an IV, along with the Bionica pump and a RQ apparatus. The Bionica pump mimics that particular patient’s liver needs, to reestablish the ability to metabolize carbohydrates. Meanwhile the RQ equipment measures the precise carbohydrate and lipid metabolic levels. This monitors how well the body is regaining normality. The patient returns once a week. Within a few weeks, the patient should start noticing a difference. Within a few months his metabolism should be restored to near normal, and the diabetic deterioration will slow, stop and even reverse itself.

Now diabetics can lead normal lives with the greatest FDA-approved breakthrough in over 80 years! Complications from this terrible disease can now be stopped — even reversed!

Diabetes is the world’s fastest-growing disease. The No. 5 killer is responsible for a QUARTER of all deaths in many parts of the world. (Many more people die from diabetes than AIDS.)

But every so often, something wonderful comes along that changes the lives of millions of people. It’s happening again with Pulse Insulin Therapy, and hundreds of thousands of people will be given new lives. Never before has a single small public company played so dominant a role in the birth of such a large “industry.” For Diabetic Treatment Centers of America the potential is truly staggering. PIT treatment will permit hundreds of thousands of patients to live again. As only diabetics can truly know what that means. Thus, Diabetic Treatment Centers of America is presenting itself as a rare opportunity for early investors.

Editing Chairman

Legal Disclosure | email preferences